Poolbeg Pharma Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Poolbeg Pharma.
Earnings growth rate
EPS growth rate
|Pharmaceuticals earnings growth||15.5%|
|Revenue growth rate||n/a|
|Future return on equity||n/a|
|Last updated||30 Mar 2023|
Recent future growth updates
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: POLB.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: POLB.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: POLB.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if POLB.F's revenue is forecast to grow faster than the US market.
High Growth Revenue: POLB.F is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if POLB.F's Return on Equity is forecast to be high in 3 years time